Latest filing published 22 May 2015 for KYNTRA BIO, INC., €292k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Julian N. Stern: trading record in brief
This profile gathers the share dealings of Julian N. Stern across 2 companies, led by Depomed Inc and Kyntra Bio, Inc. We count 65 filings; the first trade dates from 25 November 2008 and the latest from 20 May 2015.
Purchases make up the whole of the open-market record (58 purchases, €57k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 option exercises.
In size, the median ticket on the buying side is €697.
The record was last updated on 22 May 2015 with an option exercise (€292k) in Kyntra Bio, Inc. The last purchase on record was published on 26 November 2008, which is 6,556 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Julian N. Stern
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,000 shares@ US$18.00Common StockSEC:0001209191-15-046333:0
- 35,164 sharesCommon StockSEC:0001209191-14-070710:0
- 15,000 shares@ US$1.95Common StockSEC:0001179110-12-017081:0
- 10,000 shares@ US$5.80Common StockSEC:0001179110-11-011717:0
- 20,000 shares@ US$3.40Common StockSEC:0001179110-11-004262:0
- 15,000 shares@ US$3.27Common StockSEC:0001179110-09-014701:0
- 15,000 shares@ US$3.28Common StockSEC:0001179110-09-014701:1
- 656 shares@ US$1.56Common StockSEC:0001179110-08-020160:0Canonical exit: 23 Feb 2009 (T+90)
- 300 shares@ US$1.57Common StockSEC:0001179110-08-020160:1Canonical exit: 23 Feb 2009 (T+90)
- 344 shares@ US$1.55Common StockSEC:0001179110-08-020160:2Canonical exit: 23 Feb 2009 (T+90)
- 100 shares@ US$1.54Common StockSEC:0001179110-08-020160:3Canonical exit: 23 Feb 2009 (T+90)
- 100 shares@ US$1.58Common StockSEC:0001179110-08-020160:4Canonical exit: 23 Feb 2009 (T+90)
- 600 shares@ US$1.58Common StockSEC:0001179110-08-020160:5Canonical exit: 23 Feb 2009 (T+90)
- 1,000 shares@ US$1.59Common StockSEC:0001179110-08-020160:6Canonical exit: 23 Feb 2009 (T+90)
- 100 shares@ US$1.59Common StockSEC:0001179110-08-020160:7Canonical exit: 23 Feb 2009 (T+90)
- 300 shares@ US$1.54Common StockSEC:0001179110-08-020160:8Canonical exit: 23 Feb 2009 (T+90)
- 600 shares@ US$1.53Common StockSEC:0001179110-08-020160:9Canonical exit: 23 Feb 2009 (T+90)
- 600 shares@ US$1.52Common StockSEC:0001179110-08-020160:10Canonical exit: 23 Feb 2009 (T+90)
- 330 shares@ US$1.50Common StockSEC:0001179110-08-020160:11Canonical exit: 23 Feb 2009 (T+90)
- 900 shares@ US$1.51Common StockSEC:0001179110-08-020160:12Canonical exit: 23 Feb 2009 (T+90)
- 100 shares@ US$1.53Common StockSEC:0001179110-08-020160:13Canonical exit: 23 Feb 2009 (T+90)
- 1,600 shares@ US$1.60Common StockSEC:0001179110-08-020160:14Canonical exit: 23 Feb 2009 (T+90)
- 100 shares@ US$1.60Common StockSEC:0001179110-08-020160:15Canonical exit: 23 Feb 2009 (T+90)
- 300 shares@ US$1.61Common StockSEC:0001179110-08-020160:16Canonical exit: 23 Feb 2009 (T+90)
- 200 shares@ US$1.62Common StockSEC:0001179110-08-020160:17Canonical exit: 23 Feb 2009 (T+90)
25 of 62 declarations
